ECHO Biotech
ECHO Biotech
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MSC-Exosome Therapy for Frontotemporal Dementia | Frontotemporal Lobar Degeneration, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, brain disorder, central nervous system disorder, cognitive disorder, dementia, frontotemporal dementia, metabolic disease, nervous system disorder, neurodegenerative disease, proteostasis deficiencies, psychiatric disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-13 | NCT07638813 | |
| hUC-MSC-Exosomes for T2DM - Safety & Efficacy | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 1 / Phase 2 | 2026-07-09 | NCT07693036 | |
| hUC-MSC-Exo Therapy for Autoimmune Encephalitis | autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, immune system disorder, nervous system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-08-20 | NCT07131683 |